We found that high dose IT mPH-762 generated tumor-specific memory CD8+ T cells in PLOs: these cells showed tumor-specific memory reactivity as marked by expression of intracellular IFN-γ and TNF-α induced by challenge with the same tumor cell line as had been treated IT in vivo (Hepa1-6). This evidence concerns the gene CD8A and neoplasm.